|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 521.34 USD | +0.51% |
|
-0.91% | +6.70% |
| Market Cap | 22.02B 19.07B 17.78B 16.35B 30.86B 2,093B 31.21B 209B 81.98B 1,047B 82.69B 80.87B 3,469B | P/E 2026 * |
19.3x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 19.37B 16.78B 15.64B 14.38B 27.15B 1,842B 27.46B 184B 72.13B 922B 72.75B 71.15B 3,052B | EV / Sales 2026 * |
5.99x | EV / Sales 2027 * | 4.93x |
| Free-Float |
53.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
| 1 day | +0.51% | ||
| 1 week | -0.91% | ||
| Current month | +0.42% | ||
| 1 month | -5.00% | ||
| 3 months | -9.14% | ||
| 6 months | +8.55% | ||
| Current year | +6.70% |
| 1 week | 490.8 |  | 528.96 |
| 1 month | 490.8 | | 563.7 |
| Current year | 455.63 | | 609.35 |
| 1 year | 292.34 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/26 A | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 7/30/26 A | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 7/29/26 A | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.51% | -0.91% | +70.57% | +118.63% | 22.02B | |
| +3.94% | -4.48% | +50.89% | +154.53% | 995B | |
| +1.43% | -2.73% | +51.28% | +49.21% | 614B | |
| +0.65% | -6.82% | +23.56% | +63.20% | 431B | |
| +1.96% | +0.83% | +42.80% | +37.70% | 353B | |
| -0.11% | -4.07% | +30.37% | +38.52% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.56% | 245B | |
| +3.82% | +4.16% | +34.56% | +59.64% | 210B | |
| -4.32% | -12.94% | -3.79% | -46.07% | 210B | |
| -3.82% | -1.79% | +15.91% | +61.58% | 168B | |
| Average | +0.69% | -4.74% | +32.34% | +54.75% | 354.03B | |
| Weighted average by Cap. | +1.62% | -5.87% | +36.37% | +71.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.24B 2.8B 2.61B 2.4B 4.54B 308B 4.59B 30.7B 12.05B 154B 12.15B 11.89B 510B | 3.68B 3.19B 2.97B 2.73B 5.16B 350B 5.22B 34.92B 13.7B 175B 13.82B 13.52B 580B |
| Net income | 1.25B 1.08B 1.01B 925M 1.75B 118B 1.77B 11.82B 4.64B 59.27B 4.68B 4.58B 196B | 1.47B 1.28B 1.19B 1.09B 2.07B 140B 2.09B 13.99B 5.49B 70.14B 5.54B 5.42B 232B |
| Net Debt | -2.65B -2.29B -2.14B -1.96B -3.71B -252B -3.75B -25.1B -9.85B -126B -9.94B -9.72B -417B | -3.87B -3.35B -3.12B -2.87B -5.42B -368B -5.48B -36.7B -14.41B -184B -14.53B -14.21B -610B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | $520.64 | +0.38% | 400,436 |
| 04/08/26 | $518.68 | +0.46% | 522,267 |
| 03/08/26 | $516.31 | -0.27% | 427,627 |
| 31/07/26 | $517.71 | -1.54% | 616,616 |
| 30/07/26 | $525.82 | +0.21% | 472,490 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
